推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 期刊收藏夹

2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   IF范围: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
Wiley 2026暑期线上学习营 | 报名正式开启!
最高IF18.6!生命科学SCI明星期刊集锦
肿瘤免疫/自身免疫全覆盖|免疫学SCI期刊列表

按研究方向查看:


CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY期刊基本信息Hello,您是该期刊的第54822位访客

基本信息 登录收藏
期刊名字CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGYCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

CRIT REV ONCOL HEMAT
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.8
65人评分
我要评分

声誉
8.6

影响力
6.9

速度
6.7

期刊ISSN1040-8428
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
E-ISSN1879-0461
2025-2026最新IF
(数据来源于网友提供)
注册登录后,查看IF
实时影响因子 截止2026年5月06日:6.19
2025-2026自引率1.6%点击查看自引率趋势图
五年IF
(数据来源于网友提供)
6.303数据由网友[galaxy1758]收集提供
h-index 111
CiteScore
2026年6月最新版
CiteScoreSJRSNIPCiteScore排名
9.501.9771.541
学科分区排名百分位
大类:Medicine
小类:Geriatrics and Gerontology
Q19 / 123
大类:Medicine
小类:Hematology
Q116 / 151
大类:Medicine
小类:Oncology
Q160 / 428

期刊简介
Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.
期刊官方网站https://www.sciencedirect.com/journal/critical-reviews-in-oncology-hematology
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://www.editorialmanager.com/CROH
作者指南网址https://www.sciencedirect.com/journal/critical-reviews-in-oncology-hematology/publish/guide-for-authors
该期刊中国学者近期发文 - NewMapping the immune microenvironment of non-small cell lung cancer
Author: Ge, Xinyue; Cai, Mingtong; Nie, Jiayi; Wang, Linfeng; Li, Yue; Hu, Yue; Meng, Jiaqi; Liu, Hongyuan; Geng, Liang; Hua, Baojin; Liu, Rui
Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105335


Alternative splicing of immune checkpoints: Classifications, mechanisms, and therapeutic implications for overcoming immune checkpoint blockade resistance
Author: Lu, Ping; Guo, Jihua; Jia, Rong
Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105339


Next-generation in vivo CAR-T expansion strategies: Unlocking durable anti-tumor responses in solid tumors
Author: Sun, Zefeng; Wei, Lihang; Pan, Xinyi; Yan, Wenyue; Wang, Tingting; Wang, Xinyue
Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105342


Emerging treatment paradigms for gastric cancer peritoneal metastasis in the era of multimodal precision therapy
Author: Wang, Qiuli; Wang, Shulin; Yao, Jingyu; Gao, Yangjun; Wang, Wenxia; Zhao, Jun
Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105347


期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY的语言要求,还能让CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes (Hybrid,可自选是否OA)
通讯方式ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710
出版商Elsevier Ireland Ltd
涉及的研究方向医学-血液学
出版国家或地区UNITED STATES
出版语言English
出版周期Monthly
出版年份1983
年文章数 385点击查看年文章数趋势图
Gold OA文章占比31.46%
研究类文章占比:
文章 ÷(文章 + 综述)
0.00%
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 3区2区3区
ONCOLOGY
肿瘤学
4区4区2区
HEMATOLOGY
血液学
1区2区2区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区4区
HEMATOLOGY
血液学
2区3区2区
ONCOLOGY
肿瘤学
1区4区2区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区4区
HEMATOLOGY
血液学
2区3区2区
ONCOLOGY
肿瘤学
4区3区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1040-8428%5BISSN%5D
平均审稿速度网友分享经验:
偏慢,4-8周
来源Elsevier官网:
平均27.3周
平均录用比例网友分享经验:
一般
来源Elsevier官网:
83%
APC文章处理费信息
版面费:If OA, USD 4180. https://www.sciencedirect.com/journal/critical-reviews-in-oncology-hematology/publish/open-access-options
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
提交文稿
在线出版周期来源Elsevier官网:
平均8.8周
期刊常用信息链接
同领域相关期刊 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Journal of Hematology & Oncology6070.10
    BLOOD42622.80
    AMERICAN JOURNAL OF HEMATOLOGY9214.90
    LEUKEMIA17619.20
    HAEMATOLOGICA1259.70
    BLOOD REVIEWS8512.70
    SEMINARS IN HEMATOLOGY887.50
    HEMATOLOGICAL ONCOLOGY425.20
    BRITISH JOURNAL OF HAEMATOLOGY1726.60
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY704.80
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE905536
    JOURNAL OF ETHNOPHARMACOLOGY808928
    Frontiers in Immunology754747
    BIOMEDICINE & PHARMACOTHERAPY730519
    Frontiers in Pharmacology721906
    BIOMATERIALS719685
    PHYTOMEDICINE650585
    Frontiers in Oncology624728
    Biomedical Signal Processing and Control608027
    IEEE Journal of Biomedical and Health Informatics603576
  •  

    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Mapping the immune microenvironment of non-small cell lung cancer

    Author: Ge, Xinyue; Cai, Mingtong; Nie, Jiayi; Wang, Linfeng; Li, Yue; Hu, Yue; Meng, Jiaqi; Liu, Hongyuan; Geng, Liang; Hua, Baojin; Liu, Rui
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105335
        PubMed      DOI
    2.Alternative splicing of immune checkpoints: Classifications, mechanisms, and therapeutic implications for overcoming immune checkpoint blockade resistance

    Author: Lu, Ping; Guo, Jihua; Jia, Rong
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105339
        PubMed      DOI
    3.Next-generation in vivo CAR-T expansion strategies: Unlocking durable anti-tumor responses in solid tumors

    Author: Sun, Zefeng; Wei, Lihang; Pan, Xinyi; Yan, Wenyue; Wang, Tingting; Wang, Xinyue
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105342
        PubMed      DOI
    4.Emerging treatment paradigms for gastric cancer peritoneal metastasis in the era of multimodal precision therapy

    Author: Wang, Qiuli; Wang, Shulin; Yao, Jingyu; Gao, Yangjun; Wang, Wenxia; Zhao, Jun
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105347
        PubMed      DOI
    5.Efferocytosis as a Metabolic Rheostat: The Metabolic Bridge connecting TKI-induced cell death to immune tolerance in hepatocellular carcinoma

    Author: Sheng, Xiyang; Wang, Longbo; Shi, Gengyuan; Li, Yongzhao; Wang, Dongdong; Wang, Wei; Du, Yongyue; Wang, Siyang; Mi, Chen; Yang, Hanteng
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105355
        PubMed      DOI
    6.Precision medicine in bladder cancer: Redefining treatment paradigms through ADCs, immunotherapy, and molecular subtyping

    Author: Zhang, Tengyue; Gao, Zhijie; Xiao, Shuwei; Zou, Xinyi; Huang, Xinrui; Zeng, Dexian; Li, Jingyu; Wang, Yanhua
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105348
        PubMed      DOI
    7.MAIT Cells in Tumor Contexts: Functional Diversity and Regulatory Hierarchies

    Author: Wang, Kai; Jin, Kaizhou; Fei, Qinglin; Li, Tianjiao; Wang, Shuai; Yu, Xianjun; Wu, Weiding; Ye, Longyun
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105340
        PubMed      DOI
    8.Vitamin D receptor in tumors: A review of biological mechanisms, therapeutic potentials, and prognostic values

    Author: Zhang, Xiaonuo; Gao, Qianqian; Zhu, Wei; Mao, Lingxiang; Sun, Li
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105357
        PubMed      DOI
    9.Respiratory control and radiation therapy in breast cancer: Technical foundations, clinical evidence, and future directions

    Author: Marta, Gustavo Nader; Kaidar-Person, Orit; Meattini, Icro; Hijal, Tarek; Neves Junior, Wellington Furtado Pimenta; Correa, Arley Gabriel Silva; Lee, Shing Fung; Wong, Henry C. Y.; Chow, Edward; Poortmans, Philip
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105354
        PubMed      DOI
    10.Targeting the mitochondrial transfer axis in cancer: From mechanistic insights to therapeutic rewiring

    Author: Ni, Shuai; Xue, Zeng-Rong; Xin, Yuan-Yuan; Jin, Wei-Lin
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 223, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105356
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    LANCET70092.40
    MMWR Surveillance Summaries093.20
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
    Nature Reviews Disease Primers4871.30
    World Psychiatry6184.80
    同分区等级的其他期刊名称 h-index CiteScore
    MMWR Surveillance Summaries093.20
    Journal of the National Cancer Center031.20
    Carbon Neutralization018.20
    Journal of Nanostructure in Chemistry027.90
    Journal of the National Comprehensive Cancer Network8819.40
    Journal of Advanced Research3621.70
    Soft Science014.30
    NEW ASTRONOMY REVIEWS5236.80
    Wiley Interdisciplinary Reviews-Data Mining and Knowledge Discovery3126.60
    ACS Measurement Science Au014.60
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共103


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室